MoneyWorks4Me

Amrutanjan Healthcar - Quaterly Results

12 Aug 2022 Evaluate
The sales is pegged at Rs. 709.54 millions for the June 2022 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 782.12 millions during the year-ago period.The Net Profit of the company slipped to Rs. 36.64 millions from Rs. 120.57 millions, a decline of -69.61% on QoQ basis.Operating Profit reported a sharp decline to 63.42 millions from 172.91 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 709.54 782.12 -9.28 709.54 782.12 -9.28 4058.42 3328.44 21.93
Other Income 30.12 27.39 9.97 30.12 27.39 9.97 153.83 113.20 35.89
PBIDT 63.42 172.91 -63.32 63.42 172.91 -63.32 948.56 860.73 10.20
Interest 0.24 0.85 -71.76 0.24 0.85 -71.76 4.85 5.00 -3.00
PBDT 63.18 172.06 -63.28 63.18 172.06 -63.28 943.71 855.73 10.28
Depreciation 10.67 9.20 15.98 10.67 9.20 15.98 37.95 36.70 3.41
PBT 52.51 162.86 -67.76 52.51 162.86 -67.76 905.76 819.03 10.59
TAX 15.87 42.29 -62.47 15.87 42.29 -62.47 233.88 207.14 12.91
Deferred Tax -1.74 0.00 0.00 -1.74 0.00 0.00 0.00 0.00 0.00
PAT 36.64 120.57 -69.61 36.64 120.57 -69.61 671.88 611.89 9.80
Equity 29.23 29.23 0.00 29.23 29.23 0.00 29.23 29.23 0.00
PBIDTM(%) 8.94 22.11 -59.57 8.94 22.11 -59.57 23.37 25.86 -9.62
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..